Cargando…
Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases
Oligonucleotide-based therapies are advanced novel interventions used in the management of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease (COPD). These agents primarily act by gene silencing or RNA interference. Better methodologies and techniques are the need...
Autores principales: | Mehta, Meenu, Deeksha, Tewari, Devesh, Gupta, Gaurav, Awasthi, Rajendra, Singh, Harjeet, Pandey, Parijat, Chellappan, Dinesh Kumar, Wadhwa, Ridhima, Collet, Trudi, Hansbro, Philip M., Kumar, S Rajesh, Thangavelu, Lakshmi, Negi, Poonam, Dua, Kamal, Satija, Saurabh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094617/ https://www.ncbi.nlm.nih.gov/pubmed/31136735 http://dx.doi.org/10.1016/j.cbi.2019.05.028 |
Ejemplares similares
-
Plants derived therapeutic strategies targeting chronic respiratory diseases: Chemical and immunological perspective
por: Prasher, Parteek, et al.
Publicado: (2020) -
Incipient need of targeting airway remodeling using advanced drug delivery in chronic respiratory diseases
por: Mehta, Meenu, et al.
Publicado: (2020) -
Vesicular drug-delivery systems as theranostics in COVID-19
por: Satija, Saurabh, et al.
Publicado: (2020) -
Preventive role of Sapindus species in different neurological and metabolic disorders
por: Rawat, Sarita, et al.
Publicado: (2022) -
Small interfering RNA for cancer treatment: overcoming hurdles in delivery
por: Charbe, Nitin Bharat, et al.
Publicado: (2020)